Arktus Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.9M

  • Investors
  • 5

Arktus Therapeutics General Information

Description

Developer of regenerative medical technology designed for knee cartilage regeneration. The company's technology provides treatment tailored to each patient, and offers a combination of iPS cell research knowledge and three-dimensional printing technology, enabling people a natural movement and a society where people can live longer, healthier lives free from knee pain.

Contact Information

Website
www.arktustx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 104, 1st Floor, West Building of International Science Innovation Building
  • 36-1 Yoshida Hommachi, Sakyo Ward
  • Kyoto
  • Japan
Primary Industry
Therapeutic Devices
Vertical(s)
3D Printing, HealthTech
Corporate Office
  • Room 104, 1st Floor, West Building of International Science Innovation Building
  • 36-1 Yoshida Hommachi, Sakyo Ward
  • Kyoto
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arktus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 17-Apr-2024 $2.9M Completed Generating Revenue
To view Arktus Therapeutics’s complete valuation and funding history, request access »

Arktus Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
S1 Preferred
S-class preferred
To view Arktus Therapeutics’s complete cap table history, request access »

Arktus Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
HELIOS Co., Ltd. Corporation Minority
Kyoto University Innovation Capital Venture Capital Minority
Leave a Nest Capital Venture Capital Minority
MTG Ventures Corporate Venture Capital Minority
QB Capital Venture Capital Minority
To view Arktus Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Arktus Therapeutics FAQs

  • When was Arktus Therapeutics founded?

    Arktus Therapeutics was founded in 2023.

  • Where is Arktus Therapeutics headquartered?

    Arktus Therapeutics is headquartered in Kyoto, Japan.

  • What industry is Arktus Therapeutics in?

    Arktus Therapeutics’s primary industry is Therapeutic Devices.

  • Is Arktus Therapeutics a private or public company?

    Arktus Therapeutics is a Private company.

  • What is the current valuation of Arktus Therapeutics?

    The current valuation of Arktus Therapeutics is .

  • What is Arktus Therapeutics’s current revenue?

    The current revenue for Arktus Therapeutics is .

  • How much funding has Arktus Therapeutics raised over time?

    Arktus Therapeutics has raised $2.9M.

  • Who are Arktus Therapeutics’s investors?

    HELIOS Co., Ltd., Kyoto University Innovation Capital, Leave a Nest Capital, MTG Ventures, and QB Capital have invested in Arktus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »